Sphere gets regulatory OK for manufacturing products in U.K. facility

Sphere Medical has received a regulatory sign-off to make its monitoring and diagnostic products, including the Proxima arterial blood analyser, at its manufacturing facility in Harston, near Cambridge, U.K., the company notes in a release.

The U.K. company is developing a range of monitoring and diagnostic products to help in patient management. Sphere expects its products to allow near real-time measurement of blood gases, various electrolytes, glucose and drug levels at the patient's bedside. This information can enable faster clinical decision-making and improve patient outcomes, the company notes on its website.

Sphere previously had IS13485 authorization for the design and development of medical devices at the Harston facility, Proactive Investors UK notes.

"The successful completion of the audit and certification by TÜV SÜD, our notified body, validates the excellent quality management system which we have at Sphere Medical. This scope extension is an important achievement and underpins our capability for commercial manufacture at our Harston facility," said CEO Stuart Hendry in a statement.

- get the Sphere release
- here's the scoop from Proactive Investors
- check out the story from Business Weekly

Suggested Articles

Spinal Elements, maker of a wide range of implants and products for minimally invasive spine procedures, has filed a $100 million IPO.

United Airlines will begin providing COVID-19 screening tests for passengers, allowing those who test negative to skip local quarantine requirements.

Babson Diagnostics has closed its series A funding round with a total of $13.7 million and named a new CEO.